An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats

Journal of Neuroimmunology

Volumn 92, Issue 1-2, 1998, Pages 133-138

  Shin, Taekyun ^a   Tanuma, Naoyuki ^b   Kim, Seungjoon ^a   Jin, Jaekwang ^a   Moon, Changjong ^a   Kim, Kiok ^b   Kohyama, Kuniko ^b   Matsumoto, Yoh ^b   Hyun, Byunghwa ^c  

^a Jeju National University   (South Korea)

^b Tokyo Metropol Inst for N   (Japan)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Aminoguanidine; Experimental autoimmune myocarditis; Nitric oxide synthase

Indexed keywords

3 NITROTYROSINE; AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTOIMMUNE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANIDINES; MYOCARDITIS; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; TYROSINE;

EID: 0032433292     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00194-5     Document Type: Article

References (24)

1. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
2. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
3. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
4. Komada M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57:1990;250-262.
5. Komada M., Matsumoto Y., Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 85:1992;1918-1926.
6. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3024-3027.
7. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
8. Lin R.F., Lin T.S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
9. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., Cowden W.B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
10. McCartney-Francis N., Allen J.B., Misel D.E., Albina J.E., Xie Q.W., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitors of nitric oxide synthase. J. Exp. Med. 178:1993;749-754.
11. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
12. Murakami U., Uchida K., Hiratsuka T. Cardiac myosin from pig heart ventricle: purification and enzymatic properties. J. Biochem. 80:1976;611-619.
13. Murphy S., Simmons M.L., Agullo L., Carcia A., Feinstein D.L., Galea E., Reis D.J., Minc-Golomb D., Schwartz J.P. Synthesis of nitric oxide in CNS glial cells. TINS. 16:1993;323-328.
14. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
15. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
16. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;107-116.
17. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J. Neuroimmunol. 81:1998;201-210.
18. Ou P., Wolff S.P. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxidase in vitro. Biochem. Pharmacol. 46:1993;1139-1144.
19. Ruuls S.R., Van der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis by administration of nitric oxide synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-476.
20. Van Dam A.M., Bauer J., Man-A-Hing W.K.H., Marquette C., Tilders F.J.H., Berkenbosch F. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40:1995;251-260.
21. Waldburger K.E., Hastings R.C., Schaub R.G., Goldman S.J., Leonard J.P. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am. J. Pathol. 148:1996;375-382.
22. G-monomethyl-L-arginine. J. Exp. Med. 179:1994;651-660.
23. Zettl U.K., Mix E., Zielasek J., Stangel M., Hartung H.P., Gold R. Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell. Immunol. 178:1997;1-8.
24. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.